Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst
Tuesday, Guardant Health Inc GH announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket approval application (PMA) for its Shield blood test to screen for colorectal cancer on March 28, 2024. Guardant…#guardanthealthincgh #fda #pma #shield #guardanthealth #eclipse #williamblair #crc #guardant (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
Immunotherapy's Benefits for Colon Cancer Survivors Continue Long After Treatment Stops
WEDNESDAY, Dec. 20, 2023 -- Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression two years later.
That ' s the main finding from a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 20, 2023 Category: General Medicine Source Type: news
Brain imaging, ChatGPT, and medicolegal topped 2023's most read list
In this study, French researchers suggested additional PET imaging with the use of translocator protein radiotracer for observing visual brain patterns and indexing the reactivity of astrocytes, starlike cells that play a key role in central nervous system functions. The research will continue.3. UnitedHealthcare sues Radiology Partners over billing disputeWhile litigation over pass-through billing in UnitedHealthcare (United) versus Radiology Partners moved closer to arbitration as of August, details from the April court filing are worth noting. The complaint centered on a small practice that Radiology Partners acquired ...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Liz Carey Source Type: news
Patient Error Makes 1 in 10 Home Colon Cancer Tests Unusable
TUESDAY, Dec. 19, 2023 -- At-home tests for colon cancer make this important screening readily available to folks who can ’t afford or would rather not go through a colonoscopy.Unfortunately, more than 1 in 10 at-home tests sent to a lab are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 19, 2023 Category: General Medicine Source Type: news
Common 'forever chemicals' found in food and tap water could cause cancer to SPREAD in the body
A study done by Yale University researchers in Connecticut found colon cancer cells exposed to PFAS showed signs of metastasis - cancer migrating to different parts of the body. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2023 Category: Consumer Health News Source Type: news
6 Myths About IBD, Debunked
Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes with work at a design studio became an extreme exercise in perseverance. She knew in her gut that something was wrong.
Yet three different doctors “wrote it off as stress,” says Pickens, now 32, who lives in Annapolis, Md. Lab work and procedures to see inside her gastrointestinal tract showed nothing abnormal. “No one wanted to dig deeper,” she recalls. In a final act of desperation, Pickens sa...
Source: TIME: Health - December 18, 2023 Category: Consumer Health News Authors: Lindsay Lyon Tags: Uncategorized healthscienceclimate Source Type: news
PSMA-PET shows promise in patients with IBD
This study demonstrates that PSMA-targeted F-18 DCFPyL PET can effectively detect regions of inflamed mucosa in patients with IBD, suggesting its utility as a noninvasive imaging agent to assess location, extent, and disease activity,” the group concluded.The full study is available here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2023 Category: Radiology Authors: Will Morton Tags: Gastrointestinal Radiology Source Type: news
Short MRI protocol effective for assessing liver cancer treatment
This study builds on existing literature supporting the use of abbreviated liver MRI for colorectal liver metastases with the benefit of short examination times and a potential reduction in costs," she concluded. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2023 Category: Radiology Authors: Kate Madden Yee Source Type: news
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
MONDAY, Dec. 11, 2023 -- For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC) compared with other antidiabetics, including insulin... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news
Diabetes Meds Like Ozempic, Mounjaro Might Also Lower Risks for Colon Cancer
FRIDAY, Dec. 8, 2023 -- Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users ' odds for colon cancer? New research suggests they might.All of these medications (and more) fall into a class... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2023 Category: General Medicine Source Type: news
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients
(MedPage Today) -- Taking glucagon-like peptide 1 (GLP-1) receptor agonists for type 2 diabetes was associated with greater reductions in colorectal cancer (CRC) risk compared with several other diabetes medication classes, a nationwide cohort... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 7, 2023 Category: Cardiology Source Type: news
OZEMPIC-like drugs may reduce risk of one of deadliest types of cancers rising in young people, study finds
Ohio doctors have discovered a link between blockbuster obesity treatments, including Wegovy and Ozempic, and the prevention of colorectal cancer . (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2023 Category: Consumer Health News Source Type: news
Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - December 7, 2023 Category: International Medicine & Public Health Tags: Public Health Source Type: news
St. Louis startup behind colon cancer test pursuing new uses of its tech
The company inked a partnership that will expand the scope of its health screening technology beyond an initial focus on detecting colon cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2023 Category: Pharmaceuticals Authors: Nathan Rubbelke Source Type: news
Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors
WEDNESDAY, Dec. 6, 2023 -- Personalized colorectal cancer (CRC) screening based on individual life expectancy may increase the value of CRC screening programs, according to a study published online Oct. 27 in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2023 Category: Pharmaceuticals Source Type: news
